FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37493211000001106: Imbruvica 280mg tablets (Janssen-Cilag Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Aug 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
345601000001112 Imbruvica 280mg tablets (Janssen-Cilag Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
345621000001117 Imbruvica 280mg tablets (Janssen-Cilag Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Imbruvica 280mg tablets (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Imbruvica 280mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Imbruvica 280mg tablets (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Imbruvica 280mg tablets (Janssen-Cilag Ltd) Is a Ibrutinib 280mg tablets true Inferred relationship Existential restriction modifier
Imbruvica 280mg tablets (Janssen-Cilag Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Imbruvica 280mg tablets (Janssen-Cilag Ltd) Is a Imbruvica true Inferred relationship Existential restriction modifier
Imbruvica 280mg tablets (Janssen-Cilag Ltd) Has specific active ingredient Ibrutinib true Inferred relationship Existential restriction modifier
Imbruvica 280mg tablets (Janssen-Cilag Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Imbruvica 280mg tablets (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Imbruvica 280mg tablets (Janssen-Cilag Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Imbruvica 280mg tablets (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Imbruvica 280mg tablets (Janssen-Cilag Ltd) 28 tablet 2 x 14 tablets Has AMP True Imbruvica 280mg tablets (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start